Medical student UNIVERSITY OF MINNESOTA Minneapolis, Minnesota, United States
Hypothyroidism classically presents with cold intolerance, fatigue, fluid retention and dry skin. Initial presentation can also include muscular involvement with exercise intolerance, myalgias, cramping, stiffness and myoedema - a hypothyroid myopathy [1]. Cases where the muscular component of hypothyroidism is dominant may be more challenging to identify as hypothyroidism. When undiagnosed and untreated, hypothyroid myopathy can progress to more severe conditions including rhabdomyolysis [1,2]. A 45 year old female with anxiety, depression, previous substance abuse, heart failure and known fibroids presented to her primary care provider with severe muscle pain and weakness in her lower back for the past month. She noted the muscle pain made it difficult to sustain activity over 20 minutes. The pain in her lower back worsened and was attributed to known fibroid or “general musculoskeletal pain.” As the condition progressed over 2 months, the patient developed symptoms of brain fog, fatigue, water retention and weight gain (totaling approximately 50 lbs over the past 9 months) on top of the dominant myalgias and muscular symptoms. A laboratory evaluation of thyroid function and creatine kinase (CK) revealed low free T4 (<0.1 ng/dL) and T3 (0.5 pg/mL) with high TSH (78.00 μIU/mL) and thyroid peroxidase antibody (468 IU/mL) while CK was 1567 U/L with 192 U/L as the upper limit of normal for CK. The patient was diagnosed with rhabdomyolysis due to untreated severe Hashimoto's hypothyroidism. She was treated with IV fluids and PO levothyroxine (200 μg/day) and within a week myalgias improved and she was able to resume normal activities. The patient continued oral levothyroxine and hydration and has returned to normal kidney function, thyroid function and serum CK levels with abatement of myalgias. This rhabdomyolysis due to Hashimoto's hypothyroidism is a rare presentation to appreciate. This case highlights the importance of myalgias as an initial presentation for hypothyroidism. It is of note that the patient had been taking rosuvastatin for at least 18 months prior to the onset of back pain. It has been documented that individuals with untreated hypothyroidism, also taking statins for hypercholesterolemia, have developed rhabdomyolysis [1,2]. Interestingly, whereas patients with hypercholesterolemia due to hypothyroidism are often resistant to statins, this patient was managed by statins. This case serves as a reminder of statin myotoxicity risk with undiagnosed hypothyroidism. [1] Sindoni A, et al. Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. Rev Endocr Metab Disord. 2016;17(4):499-519. [2] Chiang WF, et al. Case report: Rhabdomyolysis and kidney injury in a statin-treated hypothyroid patient–kill two birds with one stone. Front Med. 2022;9.
*Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.*